|
|
|
Human Studies
(Journal Article): Synthetic exendin-4 (exenatide) significantly re-duces postprandial and fasting plasma glucose in subjects with type 2 diabetes.
Kolterman OG, Buse JB, Fineman MS, Gaines E, Heintz S, Bicsak TA, Taylor K, Kim D, Aisporna M, Wang Y, Baron AD
IN:
J Clin Endocrinol Metab
2003; 88(7):3082-3089
Impact Factor(s) of J Clin Endocrinol Metab: 5.778 (2004), 5.873 (2003), 5.16 (2001)
ABSTRACT:
Despite the advent of new treatments, glucose control in the type 2 diabetes population is unsatisfactory. AC2993 (synthetic exendin-4; exenatide), a novel glucose-dependent insuli...
Click HERE for details
|
| Contribute
to this subject area!
|
|
|
|
|
